Fresenius Medical Care (FME), the global leader in providing products and services for people with kidney diseases, is executing its strategic turnaround plan and is well on track to achieve its goals for 2024.
The board of Fresenius Medical Care AG ( ETR:FME ) has announced that it will be paying its dividend of €1.19 on the...
Fresenius Medical Care ( ETR:FME ) First Quarter 2024 Results Key Financial Results Revenue: €4.73b (flat on 1Q 2023...